Merck said it expected sales of $64.1 billion to $65.5 billion in 2025 and adjusted earnings of $8.88 to $9.03 a share. Both forecasts came in below the average analyst expectation for revenue of ...

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...

Reports Q4 revenue $15.6B, consensus $15.51B. “We delivered strong growth in 2024, reflecting demand for our innovative portfolio, including ...

Merck swung to a fourth-quarter profit as sales grew and even exceeded Wall Street’s estimates, boosted in part by the ...

Nexon has shared early update 1.2.6 patch notes for The First Descendant, and they outline some new features coming very soon.

A new patch has just gone live across Black Ops 6 and Warzone, making adjustments across multiplayer, the Battle Royale, and Zombies too.

Truist Securities expressed confidence in its latest note that Merck will be able to navigate the upcoming Gardasil headwinds ...

Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...

Drugs used for ex vivo electrophysiology were purchased from Merck, TOCRIS, and Hellobio ... For the monosynaptic rabies tracing study in Fig. 6, the brain areas containing over 1% presynaptic cells ...

FRANKFORT, Ky. – Health industry groups, business organizations and electric utilities helped drive spending on lobbying the Kentucky General Assembly to a record $28.1 million in 2024. Groups that ...